Alpha-synuclein immunoreactivity of huntingtin polyglutamine aggregates in striatum and cortex of Huntington's disease patients and transgenic mouse models

[1]  H. Lehrach,et al.  Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease. , 2001, Human molecular genetics.

[2]  J. Avruch,et al.  Calyculin A-induced Vimentin Phosphorylation Sequesters 14-3-3 and Displaces Other 14-3-3 Partners in Vivo * , 2000, The Journal of Biological Chemistry.

[3]  E. Wanker,et al.  Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Shaw,et al.  The 14-3-3 proteins , 2000, Current Biology.

[5]  B. Giasson,et al.  Chaperone‐like activity of synucleins , 2000, FEBS letters.

[6]  C A Ross,et al.  Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. , 2000, Human molecular genetics.

[7]  René Hen,et al.  Reversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's Disease , 2000, Cell.

[8]  D. Rubinsztein,et al.  Alpha-synuclein overexpression promotes aggregation of mutant huntingtin. , 2000, The Biochemical journal.

[9]  M. MacDonald,et al.  Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. , 2000, Human molecular genetics.

[10]  Anthony J. Muslin,et al.  14‐3‐3 proteins block apoptosis and differentially regulate MAPK cascades , 2000, The EMBO journal.

[11]  H. Paulson,et al.  Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70 , 1999, Nature Genetics.

[12]  D. Rubinsztein,et al.  A molecular investigation of true dominance in Huntington’s disease , 1999, Journal of medical genetics.

[13]  G P Bates,et al.  Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice. , 1999, Human molecular genetics.

[14]  D. Drubin,et al.  Sla2p is associated with the yeast cortical actin cytoskeleton via redundant localization signals. , 1999, Molecular biology of the cell.

[15]  D. Tagle,et al.  Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[16]  D. Tagle,et al.  Recent advances in understanding the pathogenesis of Huntington's disease , 1999, Trends in Neurosciences.

[17]  H. McMahon.  Endocytosis: An assembly protein for clathrin cages , 1999, Current Biology.

[18]  Min Goo Lee,et al.  Dynamic Association of Proteasomal Machinery with the Centrosome , 1999, The Journal of cell biology.

[19]  R. Myers,et al.  Impaired synaptic plasticity in mice carrying the Huntington's disease mutation. , 1999, Human molecular genetics.

[20]  N. Weigel,et al.  Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. , 1999, Human molecular genetics.

[21]  G P Bates,et al.  Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A. Parent,et al.  Neuronal degeneration in the basal ganglia and loss of pallido-subthalamic synapses in mice with targeted disruption of the Huntington's disease gene , 1999, Brain Research.

[23]  P. Bhide,et al.  Analysis of huntingtin‐associated protein 1 in mouse brain and immortalized striatal neurons , 1999, The Journal of comparative neurology.

[24]  W. Baumeister,et al.  The 26S proteasome: a molecular machine designed for controlled proteolysis. , 1999, Annual review of biochemistry.

[25]  A. Dehejia,et al.  Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease , 1998, Molecular Psychiatry.

[26]  Steven Finkbeiner,et al.  Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions , 1998, Cell.

[27]  H. Lehrach,et al.  SH3GL3 associates with the Huntingtin exon 1 protein and promotes the formation of polygln-containing protein aggregates. , 1998, Molecular cell.

[28]  Lisa Garrett,et al.  Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA , 1998, Nature Genetics.

[29]  J. Mandel,et al.  A cellular model that recapitulates major pathogenic steps of Huntington's disease. , 1998, Human molecular genetics.

[30]  S. Hersch,et al.  A Human HAP1 Homologue , 1998, The Journal of Biological Chemistry.

[31]  C. Schwarz,et al.  Wild-Type and Mutant Huntingtins Function in Vesicle Trafficking in the Secretory and Endocytic Pathways , 1998, Experimental Neurology.

[32]  David F. Clayton,et al.  The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease , 1998, Trends in Neurosciences.

[33]  S. W. Davies,et al.  Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A. Hackam,et al.  Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates , 1998, Nature Genetics.

[35]  T Tukamoto,et al.  Huntington's disease gene product, huntingtin, associates with microtubules in vitro. , 1997, Brain research. Molecular brain research.

[36]  H. Riezman,et al.  End4p/Sla2p interacts with actin-associated proteins for endocytosis in Saccharomyces cerevisiae. , 1997, Molecular biology of the cell.

[37]  R. Plemper,et al.  Mutant analysis links the translocon and BiP to retrograde protein transport for ER degradation , 1997, Nature.

[38]  Hans Lehrach,et al.  Huntingtin-Encoded Polyglutamine Expansions Form Amyloid-like Protein Aggregates In Vitro and In Vivo , 1997, Cell.

[39]  R. Vallee,et al.  Fast transport and retrograde movement of huntingtin and HAP 1 in axons , 1997, Neuroreport.

[40]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[41]  H. Lehrach,et al.  HIP-I: a huntingtin interacting protein isolated by the yeast two-hybrid system. , 1997, Human molecular genetics.

[42]  S E Ide,et al.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.

[43]  S. Schmid,et al.  Clathrin-coated vesicle formation and protein sorting: an integrated process. , 1997, Annual review of biochemistry.

[44]  C. Chiang,et al.  Establishment of stable cell lines expressing potentially toxic proteins by tetracycline-regulated and epitope-tagging methods. , 1996, BioTechniques.

[45]  P S Harper,et al.  Partial characterisation of murine huntingtin and apparent variations in the subcellular localisation of huntingtin in human, mouse and rat brain. , 1996, Human molecular genetics.

[46]  R. Vallee,et al.  Targeting of Motor Proteins , 1996, Science.

[47]  S. Snyder,et al.  A huntingtin-associated protein enriched in brain with implications for pathology , 1995, Nature.

[48]  Satoshi Omura,et al.  Degradation of CFTR by the ubiquitin-proteasome pathway , 1995, Cell.

[49]  D. Pollen,et al.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.

[50]  E. Hirsch,et al.  Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form , 1995, Nature Genetics.

[51]  Christopher A Ross,et al.  Widespread expression of Huntington's disease gene (IT15) protein product , 1995, Neuron.

[52]  C. Ross,et al.  Expression of the mutant allele of IT-15 (the HD gene) in striatum and cortex of Huntington's disease patients. , 1995, Human molecular genetics.

[53]  S. Zhou,et al.  Characterization of a novel synapse-specific protein. II. cDNA cloning and sequence analysis of the F1-20 protein , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[54]  N. Roehm,et al.  An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. , 1991, Journal of immunological methods.

[55]  M Unser,et al.  Molecular substructure of a viral receptor-recognition protein. The gp17 tail-fiber of bacteriophage T7. , 1988, Journal of molecular biology.

[56]  J. Penney,et al.  Homozygotes for Huntington's disease , 1987, Nature.

[57]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[58]  E. Reynolds.  THE USE OF LEAD CITRATE AT HIGH pH AS AN ELECTRON-OPAQUE STAIN IN ELECTRON MICROSCOPY , 1963, The Journal of cell biology.

[59]  T. Reed,et al.  Huntington's chorea in Michigan. I. Demography and genetics. , 1958, American journal of human genetics.